The overall impact of COPD (CAT) and BODE index on COPD male patients: Correlation?

Revista Portuguesa de Pneumologia

Volumn 21, Issue 1, 2015, Pages 11-15

  Ladeira, I ^a   Gomes, T ^a   Castro, A ^b   Ribeiro, C ^a   Guimaraes M ^b   Taveira, N ^b  

^a EPE   (Portugal)

^b CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

Author keywords

BODE index; CAT; COPD; Quality of life; Respiratory rehabilitation

Indexed keywords

BRONCHODILATING AGENT;

ADULT; ARTICLE; BODY MASS; BODY MASS INDEX AIRFLOW; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RESPIRATORY FUNCTION; COMPLICATION; EXERCISE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; RETROSPECTIVE STUDY; SICKNESS IMPACT PROFILE;

BODY MASS INDEX; DYSPNEA; EXERCISE TOLERANCE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SICKNESS IMPACT PROFILE; SURVEYS AND QUESTIONNAIRES;

EID: 84976877637     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rppnen.2014.02.004     Document Type: Article

References (25)

1. Mathers CD, Loncar D. Updated projections of global mortalityand burden of disease, 2002-2030: data sources, methods and results. Geneva: WHO; 2005.
2. Bárbara C, Rodrigues F, Dias H, Cardoso J, Almeida J, Matos MJ, et al. Chronic obstructive pulmonary disease prevalence inlisbon, portugal: the burden of obstructive lung disease study.Rev Port Pneumol. 2013;19:96-105.
3. Global strategy for diagnosis management, and preventionof COPD; 2010. Updated 2010. Available from http://www.goldcopd.com
4. Global initiative for chronic obstructive lung disease (GOLD)guideline: global strategy for the diagnosis, management andprevention of chronic obstructive pulmonary disease; 2011(revised 2011) www.goldcopd.com
5. Jones PW, Quirk FH, Baveystock CM. The St George's respiratoryquestionnaire. Respir Med. 1991;85 Suppl. B:25-31.
6. Williams JE, Singh SJ, Sewell L, Guyatt GH, Morgan MD. Devel-opment of a self-reported Chronic Respiratory Questionnaire(CRQ-SR). Thorax. 2001;56:954.
7. Van der Molen T, Willemse BW, Schokker S, ten Hacken NH,Postma DS, Juniper EF. Development, validity and responsive-ness of the Clinical COPD Questionnaire. Health Qual LifeOutcomes. 2003;1:1-13.
8. Jones PW, Harding G, Berry P, Wiklund L, Chen W-H, Kline Leidy N. Development and first validation of the COPD AssessmentTest. Eur Respir J. 2009;34:648-65.
9. Cave AJ, Tsiligianni I, Chavannes N, Correia de Sousa J,Yaman H. IPCRG users' guide to COPD 'wellness' tools.International Primary Care Respiratory Group; 2010. Septem-ber, http://www.theipcrg.org/resources/ipcrg users guide tocopd wellness tools.pdf [Version current 16.04.11].
10. Agustí A, Soler JJ, Molina J, Mu-oz MJ, García-Losa M, Roset M,et al. Is the CAT questionnaire sensitive to changes in healthstatus in patients with severe COPD exacerbations? COPD.2012;9:492-8.
11. da Silva GP, Morano MT, Viana CM, Magalhães CB, Pereira ED.Portuguese-language version of the COPD Assessment Test: vali-dation for use in Brazil. J Bras Pneumol. 2013;39:402-8.
12. Jones Paul W, Tabberer M, Chen W-H. Creating scenarios of theimpact of COPD and their relationship to COPD assessment test(CAT) Scores. BMC Pulm Med. 2011;11:42.
13. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M,Mendez RA, et al. The body-mass index, airflow obstruction,dyspnea, and exercise capacity index in chronic obstructivepulmonary disease. N Engl J Med. 2004;350:1005-12.
14. Celli BR. Change in the BODE index reflects disease modificationin COPD: lessons from lung volume reduction surgery. Chest.2006;129:835-6.
15. Ong KC, Earnest A, Lu SJ. A multidimensional grading system(BODE index) as predictor of hospitalization for COPD. Chest.2005;128:3810-6.
16. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE indexin COPD. Eur Respir J. 2005;26:630-6.
17. Imfeld S, Block KE, Weder W, Russi EW. The BODE index afterlung volume reduction surgery correlates with survival. Chest.2006;129:873-8.
18. Lin YX, Xu WN, Liang LR, Wang CC, Tseng CC, Chin CH, et al.The cross-sectional and longitudinal association of the BODEindex with quality of life in patients with chronic obstructivepulmonary disease. Chin Med J (Engl). 2009;122:2939-44.
19. Amoros MM, Mas-Tous C, Renom-Sotorra F, Rubi-Ponseti M,Centeno-Flores MJ, Gorriz-Dolz MT. Health-related quality oflife is associated with COPD severity: a comparison betweenthe GOLD staging and the BODE index. Chron Respir Dis.2009;6:75-80.
20. Medinas-Amoros M, Alorda C, Renom F, Rubí M, Centeno J, Fer-rer V, et al. Quality of life in patients with chronic obstructivepulmonary disease: the predictive validity of the BODE index.Chron Respir Dis. 2008;5:7-11.
21. Liu SF, Tseng CW, Tu ML, Wang CC, Tseng CC, Chin CH, et al.The clinical COPD questionnaire correlated with BODE Index-ACross-Sectional Study. Sci World J. 2012;2012:361535.
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R,Coates A, et al. Standardisation of spirometry. Eur Respir J.2005;26:319-38.
23. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoeascale as a measure of disability in patients with chronic obstruc-tive pulmonary disease. Thorax. 1999;54:581-6.
24. Fabbri LM, Rabe KF. From COPD to chronic systemic inflamma-tory syndrome? Lancet. 2007;370:797-9.
25. Funk G, Kirchheiner K, Burghuber OC, Hartl S. BODE index versusGOLD classification for explaining anxious and depressive symp-toms in patients with COPD - a cross-sectional study. Respir Res.2009;10:1.